Literature DB >> 11307864

Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome.

M A Alpert1.   

Abstract

Obesity produces an increase in total blood volume and cardiac output because of the high metabolic activity of excessive fat. In moderate to severe cases of obesity, this may lead to left ventricular dilation, increased left ventricular wall stress, compensatory (eccentric) left ventricular hypertrophy, and left ventricular diastolic dysfunction. Left ventricular systolic dysfunction may occur if wall stress remains high because of inadequate hypertrophy. Right ventricular structure and function may be similarly affected by the aforementioned morphologic and hemodynamic alterations and by pulmonary hypertension related to the sleep apnea/ obesity hypoventilation syndrome. The term obesity cardiomyopathy is applied when these cardiac structural and hemodynamic changes result in congestive heart failure. Obesity cardiomyopathy typically occurs in persons with severe and long-standing obesity. The predominant causes of death in those with obesity cardiomyopathy are progressive congestive heart failure and sudden cardiac death.

Entities:  

Mesh:

Year:  2001        PMID: 11307864     DOI: 10.1097/00000441-200104000-00003

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  169 in total

Review 1.  Cardiovascular consequences of obese and nonobese obstructive sleep apnea.

Authors:  Kannan Ramar; Sean M Caples
Journal:  Med Clin North Am       Date:  2010-05       Impact factor: 5.456

Review 2.  Is the 'athlete's heart' arrhythmogenic? Implications for sudden cardiac death.

Authors:  Thomas Rowland
Journal:  Sports Med       Date:  2011-05-01       Impact factor: 11.136

3.  Supplemental postoperative oxygen and tissue oxygen tension in morbidly obese patients.

Authors:  Barbara Kabon; Romana Rozum; Corinna Marschalek; Gerhard Prager; Edith Fleischmann; Astrid Chiari; Andrea Kurz
Journal:  Obes Surg       Date:  2010-07       Impact factor: 4.129

Review 4.  Heart failure and obesity in adults: pathophysiology, clinical manifestations and management.

Authors:  Martin A Alpert; Harsh Agrawal; Kul Aggarwal; Senthil A Kumar; Arun Kumar
Journal:  Curr Heart Fail Rep       Date:  2014-06

Review 5.  Nutrigenetics-personalized nutrition in obesity and cardiovascular diseases.

Authors:  Luigi Barrea; Giuseppe Annunziata; Laura Bordoni; Giovanna Muscogiuri; Annamaria Colao; Silvia Savastano
Journal:  Int J Obes Suppl       Date:  2020-07-20

6.  Disruption of calpain reduces lipotoxicity-induced cardiac injury by preventing endoplasmic reticulum stress.

Authors:  Shengcun Li; Lulu Zhang; Rui Ni; Ting Cao; Dong Zheng; Sidong Xiong; Peter A Greer; Guo-Chang Fan; Tianqing Peng
Journal:  Biochim Biophys Acta       Date:  2016-08-12

7.  Cardiac remodeling in obese patients after laparoscopic sleeve gastrectomy.

Authors:  Elena Cavarretta; Giovanni Casella; Benedetto Calì; Carmelisa Dammaro; Giuseppe Biondi-Zoccai; Angelo Iossa; Frida Leonetti; Giacomo Frati; Nicola Basso
Journal:  World J Surg       Date:  2013-03       Impact factor: 3.352

8.  Effect of moderate diet-induced weight loss and weight regain on cardiovascular structure and function.

Authors:  Lisa de las Fuentes; Alan D Waggoner; B Selma Mohammed; Richard I Stein; Bernard V Miller; Gary D Foster; Holly R Wyatt; Samuel Klein; Victor G Davila-Roman
Journal:  J Am Coll Cardiol       Date:  2009-12-15       Impact factor: 24.094

9.  Assessment of Atrial Fibrillation and Ventricular Arrhythmia Risk after Bariatric Surgery by P Wave/QT Interval Dispersion.

Authors:  Mustafa Yılmaz; Cihan Altın; Abdullah Tekin; Tansel Erol; İlker Arer; Tarık Zafer Nursal; Nurkan Törer; Varlık Erol; Haldun Müderrisoğlu
Journal:  Obes Surg       Date:  2018-04       Impact factor: 4.129

10.  Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies.

Authors:  J Malcom; O Arnold; Jonathan G Howlett; Anique Ducharme; Justin A Ezekowitz; Martin J Gardner; Nadia Giannetti; Haissam Haddad; George A Heckman; Debra Isaac; Philip Jong; Peter Liu; Elizabeth Mann; Robert S McKelvie; Gordon W Moe; Anna M Svendsen; Ross T Tsuyuki; Kelly O'Halloran; Heather J Ross; Errol J Sequeira; Michel White
Journal:  Can J Cardiol       Date:  2008-01       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.